Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells
- PMID: 7772068
- DOI: 10.1016/0021-9150(94)05400-d
Lysophosphatidylcholine causes Ca2+ influx, enhanced DNA synthesis and cytotoxicity in cultured vascular smooth muscle cells
Abstract
The effects of lysophosphatidylcholine (LPC), a vasoactive phospholipid, on intracellular free calcium concentration ([Ca2+]i), DNA synthesis and cytotoxicity of vascular smooth muscle cells (VSMC) were studied. LPC from 10(-7) to 10(-5) mol/l dose-dependently induced a sustained increase in [Ca2+]i. In contrast to the response of [Ca2+]i induced by angiotensin II, that induced by LPC was totally abolished when extracellular Ca2+ was removed, was not affected by pretreatment of the cells with islet-activating protein, and was not desensitized by repeated addition. 8-(N,N-Diethylamino)octyl 3,4,5-trimethoxybenzoic acid (TMB-8), an inhibitor of Ca2+ release from intracellular Ca2+ stores, 1-(5-isoquinolinesulfonyl)-2-methylpiperadine dihydrochloride (H-7), an inhibitor of protein kinase C, KT5823, an inhibitor of protein kinase G, and Ca2+ channel blockers failed to suppress the LPC-induced increase in [Ca2+]i. LPC at 10(-5) mol/l caused significant stimulation of [3H]thymidine incorporation into VSMC, and at concentrations of 10(-5) mol/l and higher dose-dependently stimulated release of lactate dehydrogenase in cell culture supernatants. Moreover, digitonin mimicked the effects of LPC on [Ca2+]i, and also caused similar effects to those of LPC on DNA synthesis and cytotoxicity in VSMC. These observations suggest that LPC causes both cell growth and cell injury of VSMC, at least partly, through its detergent action, causing membrane leakiness and resultant [Ca2+]i overload in vitro, thus indicating the possible participation of LPC in atherosclerosis and/or injury of the vascular wall.
Similar articles
-
The effects of angiotensin II, endothelin-1, and protein kinase C inhibitor on DNA synthesis and intracellular calcium mobilization in vascular smooth muscle cells from young normotensive and spontaneously hypertensive rats.Am J Hypertens. 1999 Dec;12(12 Pt 1-2):1243-51. doi: 10.1016/s0895-7061(99)00158-2. Am J Hypertens. 1999. PMID: 10619588
-
Nonselective cation currents regulate membrane potential of rabbit coronary arterial cell: modulation by lysophosphatidylcholine.Circulation. 2002 Dec 10;106(24):3111-9. doi: 10.1161/01.cir.0000039345.00481.1d. Circulation. 2002. PMID: 12473560
-
Marked dissociation between intracellular Ca2+ level and contraction on exposure of rat aorta to lysophosphatidylcholine.Eur J Pharmacol. 1999 Aug 6;378(2):177-86. doi: 10.1016/s0014-2999(99)00458-6. Eur J Pharmacol. 1999. PMID: 10478630
-
[Cardiac cell injury induced by lysophosphatidylcholine].Nihon Yakurigaku Zasshi. 1999 Nov;114(5):287-93. doi: 10.1254/fpj.114.287. Nihon Yakurigaku Zasshi. 1999. PMID: 10621942 Review. Japanese.
-
Cell cycle dependent regulation of intracellular calcium concentration in vascular smooth muscle cells: a potential target for drug therapy.Curr Drug Targets Cardiovasc Haematol Disord. 2001 Jun;1(1):23-40. doi: 10.2174/1568006013338060. Curr Drug Targets Cardiovasc Haematol Disord. 2001. PMID: 12769662 Review.
Cited by
-
Stimulatory and inhibitory actions of lysophosphatidylcholine, depending on its fatty acid residue, on the phospholipase C/Ca2+ system in HL-60 leukaemia cells.Biochem J. 1998 Dec 1;336 ( Pt 2)(Pt 2):491-500. doi: 10.1042/bj3360491. Biochem J. 1998. PMID: 9820828 Free PMC article.
-
Lysophosphatidylcholine activates transcription factor NF-kappaB and AP-1 in AR42J cells.Dig Dis Sci. 2001 Sep;46(9):1871-81. doi: 10.1023/a:1010622828502. Dig Dis Sci. 2001. PMID: 11575438
-
Lyso-phosphatidylcholine induces osteogenic gene expression and phenotype in vascular smooth muscle cells.Atherosclerosis. 2010 Jul;211(1):122-9. doi: 10.1016/j.atherosclerosis.2010.04.005. Epub 2010 Apr 14. Atherosclerosis. 2010. PMID: 20451909 Free PMC article.
-
Sarcophine-diol inhibits expression of COX-2, inhibits activity of cPLA2, enhances degradation of PLA2 and PLC(γ)1 and inhibits cell membrane permeability in mouse melanoma B16F10 cells.Mar Drugs. 2012 Oct;10(10):2166-2180. doi: 10.3390/md10102166. Epub 2012 Sep 28. Mar Drugs. 2012. PMID: 23170076 Free PMC article.
-
Lysophosphatidylcholine Increases Ca Current via Activation of Protein Kinase C in Rabbit Portal Vein Smooth Muscle Cells.Korean J Physiol Pharmacol. 2008 Feb;12(1):31-5. doi: 10.4196/kjpp.2008.12.1.31. Epub 2008 Feb 28. Korean J Physiol Pharmacol. 2008. PMID: 20157391 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous